Tilray/$TLRY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Tilray

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Ticker

$TLRY
Primary listing

Industry

Pharmaceuticals

Headquarters

Leamington, Canada

Employees

2,650

Tilray Metrics

BasicAdvanced
$673M
-
-$2.46
1.90
-

What the Analysts think about Tilray

Analyst ratings (Buy, Hold, Sell) for Tilray stock.

Bulls say / Bears say

Tilray's diversified operations across four key segments—Beverage Alcohol, Cannabis, Distribution, and Wellness—position the company to leverage synergies and mitigate risks associated with reliance on a single product line. (directorstalkinterviews.com)
Analysts have set an average price target of $1.38 for Tilray, suggesting a potential upside of approximately 125% from its current trading price. (stockanalysis.com)
Tilray's recent acquisition of eight beverage brands from Anheuser-Busch, including HiBall Energy, expands its product portfolio and could enhance revenue streams. (wikipedia.org)
Tilray reported a 1.4% year-over-year decline in revenue for Q1 CY2025, missing Wall Street's expectations and indicating potential challenges in maintaining growth. (stockstory.org)
The company's earnings per share (EPS) stand at -$1.10, reflecting ongoing profitability challenges and raising concerns about its financial health. (directorstalkinterviews.com)
Tilray's stock has experienced significant volatility, with a 52-week range between $0.35 and $2.15, which may deter risk-averse investors. (cnbc.com)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Tilray Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Tilray Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TLRY

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs